Angiojet rheolytic thrombectomy in massive pulmonary embolism: locally efficacious but systemically deleterious?

摘要

We congratulate Kuo et al (1) for their landmark meta-analysis of the recent studies on feasibility, safety, and efficacy of percutaneous mechanical thrombectomy (PMT) in massive pulmonary embolism (PE). We agree with the conclusion of the authors that in the near future, PMT may become first-line therapy for patients with massive PE, especially in the presence of contraindications to systemic intravenous thrombolysis. As pointed out in the article, larger studies are needed, however, to define the exact role of PMT-alone or in combination with low-dose in situ thrombolysis-in this life-threatening condition.